This randomized controlled trial evaluated the long-term outcomes of monitoring, surgery, or radiotherapy in patients with localized prostate cancer. Over a 10-year period, the study found no significant differences in prostate cancer-specific mortality between the three treatment groups. However, surgery and radiotherapy were associated with higher rates of erectile dysfunction
